Related Experiment Video

Updated: Aug 15, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

Negative regulation of ErbB family receptor tyrosine kinases

C Sweeney1, K L Carraway

  • 1UC Davis Cancer Center, University of California, Research Building III, Room 1400, 4645 2nd Avenue, Davis, Sacramento CA 95817, USA. casweeney@ucdavis.edu

British Journal of Cancer
|January 22, 2004
PubMed

Insights

Epidermal Growth Factor Receptor (EGFR) family signaling is crucial in solid tumors. New research identifies endogenous proteins that negatively regulate EGFR signaling, offering potential new cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Epidermal Growth Factor Receptor (EGFR) or ErbB family tyrosine kinases are often overexpressed in solid tumors.
  • Aberrant activation of ErbB signaling contributes to tumor growth and progression.
  • Targeted therapies, including antibodies and small molecules, have shown clinical success in inhibiting ErbB receptors.

Purpose of the Study:

  • To review the role of endogenous negative regulatory proteins in suppressing ErbB receptor signaling.
  • To explore the potential therapeutic benefit of restoring these negative regulatory pathways in cancer treatment.

Main Methods:

  • Literature review of identified endogenous negative regulatory proteins.
  • Discussion of intracellular (e.g., cbl, Nrdp1) and extracellular mechanisms of ErbB regulation.
  • Analysis of the role of these pathways in tumor progression.

Main Results:

  • Identification of intracellular RING finger E3 ubiquitin ligases (cbl, Nrdp1) mediating ErbB receptor degradation.
  • Recognition of various secreted and transmembrane proteins that inhibit growth factor ligand binding.
  • Hypothesis that tumor cells may suppress these negative regulatory pathways for progression.

Conclusions:

  • Endogenous negative regulatory proteins play a significant role in controlling ErbB signaling.
  • Understanding how tumors suppress these pathways is key to developing novel cancer therapies.
  • Restoring these natural inhibitory mechanisms presents a promising therapeutic strategy for cancer treatment.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...